west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "甲状腺功能" 59 results
  • 131I 治疗甲状腺功能亢进症伴2型糖尿病的护理

    目的 总结甲状腺功能亢进症(甲亢)合并2 型糖尿病患者的护理方法。 方法 对2008年3月-2011年10月期间核医学科收治的20例经131I治疗的甲亢伴2型糖尿病患者的临床治疗中的护理进行回顾性分析。 结果 通过131I治疗与核医学科专科护理,20例患者中有18例甲状腺功能恢复至正常水平或得到改善,12例空腹血糖水平控制在(6.0 ± 1.2)mmol/L,餐后2 h 血糖水平控制在(7.9 ± 1.7)mmol/L。 结论 核医学科专科护理有助于131I治疗甲亢合并2 型糖尿病患者的病情控制,减少并发症的发生。

    Release date: Export PDF Favorites Scan
  • Reoperation of Hyperthyroidism (Report of 32 Cases)

    Release date:2016-08-28 04:30 Export PDF Favorites Scan
  • To Show the Thyroid Surgery in Chinese

    Release date:2016-08-28 04:44 Export PDF Favorites Scan
  • 选择性血管离断术治疗难控制性甲状腺功能亢进症(附11例报告)

    Release date:2016-08-29 09:18 Export PDF Favorites Scan
  • THE CLINICAL FEATURE OF GRAVES’ DISEASE ASSOCIATED WITH THYROID CANCER

    From 1972 to 1992, 333 patients underwent operations because of Graves’ disease in our hospital. Histological examination of resected thyroid tissue revealed carcinoma in 8 cases, which accounted for 2.4%(8/333). With reviewing the literatures basing on a lot of literature, we lay emphasis on the clinical feature of the disease, cause of misdiagnosis, and the diagnosis and treatment of the disease are discussed.

    Release date:2016-08-29 03:19 Export PDF Favorites Scan
  • The Diagnosis and Treatment of Pulmonary Arterial Hypertension Due to Rare Causes

    Objective To investigate the diagnosis and treatment of pulmonary arterial hypertension ( PAH) due to rare causes. Methods The clinical presentation, laboratory testing, diagnosis and treatment of 4 patients with PAH associated with rare causes in Beijing Anzhen Hospital from January 2001 to March 2008 were analysed retrospectively. Results Primary biliary cirrhosis, hyperthyroidism, antiphospholipid syndrome and pulmonary artery sarcoma may cause PAH, which were improved after corresponding diagnosis and management. Conclusion PAH can result from rare causes. The enhancement of its recognition will help earlier diagnosis and treatment and improve the prognosis.

    Release date:2016-09-14 11:22 Export PDF Favorites Scan
  • 心脏病合并甲状腺功能减退症患者的外科治疗

    目的 总结心脏病合并甲状腺功能减退症患者行外科手术治疗的临床经验。 方法 回顾性分析2001年9月至2009年5月解放军总医院19例心脏病合并甲状腺功能减退症患者行外科手术治疗的临床资料,男7例,女12例;年龄50~76岁,平均年龄63.20岁。冠心病15例,主动脉瓣狭窄1例,房间隔缺损1例,慢性心包炎2例;均合并甲状腺功能减退症。所有患者术前给予左旋甲状腺素钠(40~120 mg/d)口服治疗,根据其耐受程度、促甲状腺激素和甲状腺激素水平调整用量,将甲状腺激素水平调整至基本正常。行体外循环冠状动脉旁路移植术6例,非体外循环冠状动脉旁路移植术9例,房间隔缺损修补术1例,主动脉瓣置换术1例,心包剥脱术2例。术后按原剂量或加量口服左旋甲状腺素钠片,检测手术前、后甲状腺激素指标的改变。 结果 无手术死亡,术后所有患者均未发生低三碘甲状腺原氨酸(T3)综合征,甲状腺功能指标与术前比较均有不同程度的降低,以血清总三碘甲状腺原氨酸和血清游离三碘甲状腺原氨酸降低最为明显,体外循环手术患者下降幅度更大。术后继续给予甲状腺素钠口服,并持续服用维持量的甲状腺素钠。随访19例,随访时间4~7个月,随访期间均持续服用维持量的甲状腺素钠,心功能分级(NYHA)Ⅰ级14例,Ⅱ级5例;患者恢复正常生活。 结论 合并甲状腺功能减退症的心脏病患者行心脏手术是安全、可行的,体外循环和非体外循环心脏手术后甲状腺激素均有所降低,体外循环手术患者下降更明显,术后应警惕发生低T3综合征和低T3、T4综合征。

    Release date:2016-08-30 05:57 Export PDF Favorites Scan
  • Coronary Artery Bypass Grafting for Coronary Artery Disease Patients with Completed Hypothyroidism

    Abstract: Objective To investigate the clinical results of the coronary artery bypass grafting (CABG) for coronary artery disease (CAD) patients with completed hypothyroidism. Methods Twentyone CAD patients with hypothyroidism (hypothyroidism group) operated by a single surgeon from September 2002 to June 2009 in our department were enrolled in this study. Among them, there were 6 males and 15 females. Their average age was 60.4 years old. Three patients underwent CABG with onpump beating heart; one underwent CABG with onpump arrested heart; and 17 patients underwent CABG with offpump beating heart. All patients on thyroxine replacement therapy underwent CABG after free triiodothyronine(FT3),free thyroxin(FT4), thyroidstimulating hormone(TSH), total triiodothyronine(TT3) and total thyroxin(TT4) were obviously improved. At the same time, twenty CAD patients without hypothyroidism were chosen as the control group (control group). Among them, there were 6 males and 14 females with an average age of 62.1 years old. The data of thyroid gland function and clinical prognostic indicator were observed after the operation. Results For the hypothyroidism group, one patient with pericardial effusion, heart failure and low thyroxine before surgery died during the onpump operation. Among the 20 survivors who had undergone CABG with beating heart, 17 were offpump CABG patients. Followup was done for 230 months. Postoperative eject factor of the survivors were significantly higher than their preoperative eject factor (55%±21% vs. 48%±17%). Twenty patients in the control group all survived. There was no significant difference in cardiac index [2.7±1.4 L/(min·m2) vs. 2.8±1.5 L/(min·m2), t=0.530, P=0.530], hospital stay (12.2±4.7 d vs. 10.1±3.9 d , t=0.170, P=0.170), or mechanical ventilation time (17.6±9.1 h vs. 15.1±13.7 h, t=0.120, P=0.120) between the hypothyroidism group and the control group. Perioperative thyroxine examination showed that there was no profound impact on thyroxine by offpump CABG. Conclusions With full preparation made before operation, CABG with beating heart is comparatively safe for CAD patients with hypothyroidism. The key of the treatment is perioperative thyroxine replacement therapy. There is much risk to perform onpump CABG on patients with severe hypothyroidism.

    Release date:2016-08-30 06:02 Export PDF Favorites Scan
  • T3对心肌细胞肌浆网钙ATP酶基因表达的影响及其对心肌保护的基因调控作用

    目的 研究不同甲状腺功能状态下,鼠缺血再灌注(Ischemia-reperfusion, I/R)心肌细胞肌浆网钙三磷酸腺苷酶(SRCa2+-ATPase)基因(SERCA2a)表达的变化,以及三碘甲状腺原氨酸(T3)对其变化的影响;探讨基因调控在心肌保护中的作用。方法 将实验大鼠随机分为甲状腺功能正常组(A组),甲状腺功能减退组(B组),两组又分别分为正常对照组、单纯灌注液组、T3灌注液组;利用离体心工作模型进行灌注;采用Northern-Blot方法测定各组心肌细胞SERCA2a mRNA的相对含量。结果 B组心肌细胞、I/R心肌细胞SERCA2a mRNA的表达均明显下降,而T3灌注液组其mRNA含量均显著提高,A组和B组中单纯灌注液组与T3灌注液组比较差别具有显著性意义(P<0.01),其变化状态与其心肌功能变化一致。结论 基因SERCA2a表达的显著下降是心肌I/R损伤的重要机制;T3是SERCA2a基因表达的促进剂,在I/R过程中可增强SERCA2a基因的表达,起到保护I/R心肌细胞、增强心肌功能的作用。

    Release date:2016-08-30 06:34 Export PDF Favorites Scan
  • 甲状腺动脉介入栓塞并发视网膜分支动脉阻塞一例

    Release date:2016-09-02 06:07 Export PDF Favorites Scan
6 pages Previous 1 2 3 ... 6 Next

Format

Content